194 related articles for article (PubMed ID: 18835621)
1. Comparative analysis of protein expressions in primary and metastatic gastric carcinomas.
Kim JH; Kim MA; Lee HS; Kim WH
Hum Pathol; 2009 Mar; 40(3):314-22. PubMed ID: 18835621
[TBL] [Abstract][Full Text] [Related]
2. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Liu J; Ikeguchi M; Nakamura S; Kaibara N
J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
4. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
5. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
[TBL] [Abstract][Full Text] [Related]
6. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
8. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
[TBL] [Abstract][Full Text] [Related]
10. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
11. Loss of KAI1 expression in gastric cancer.
Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H
Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050
[TBL] [Abstract][Full Text] [Related]
12. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
13. Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue.
Bazas VM; Lukyanova NY; Lisovenko GS; Rozumiy DO; Potebnya GP
Exp Oncol; 2009 Sep; 31(3):182-4. PubMed ID: 19783961
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
Yu DQ; Yi YF
Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
[TBL] [Abstract][Full Text] [Related]
17. Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer.
Asioli S; Maletta F; Verdun di Cantogno L; Satolli MA; Schena M; Pecchioni C; Botta C; Chiusa L; Molinaro L; Conti L; Viale G; Ingravallo G; Maiorano E; Sapino A
Hum Pathol; 2012 Nov; 43(11):2070-9. PubMed ID: 22658277
[TBL] [Abstract][Full Text] [Related]
18. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma.
Kim JH; Park JM; Jung CW; Park SS; Kim SJ; Mok YJ; Kim CS; Chae YS; Bae JW
J Surg Oncol; 2008 Feb; 97(2):125-30. PubMed ID: 18095267
[TBL] [Abstract][Full Text] [Related]
19. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
20. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.
Yokoyama Y; Sagara M; Sato S; Saito Y
Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
